3m
Abstract Autophagy is a tightly controlled process comprising lysosomal degradation and recycling of cellular proteins and organelles. In cancer, its paradoxical dual role of cytoprotection and cytotoxicity is context-dependent and controversial. Autophagy primarily acts as a mechanism...
18m
Journal of Cutaneous Pathology,Volume 0, Issue ja, -Not available-. (Source: Journal of Cutaneous Pathology)
18m
Cytopathology, EarlyView. (Source: Cytopathology)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
18m
ConclusionsOur data compare favorably to a theoretical cohort suggesting a clinically reasonable cut-off of > 11 mm endometrial thickness to discriminate between "normal" and "pathological". The data regarding "risk for endometrial cancer" can be used for counseling affected women. (Source: Archives...
24m
Conditions: Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer; Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer; Metastatic Gastric Adenocarcinoma or Cancer; Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma Interventions: Drug: zolbetuximab;...
24m
Conditions: Non-small Cell Lung Cancer; EGFR Gene Mutation; Brain Metastases Interventions: Drug: AZD3759; Drug: Erlotinib; Drug: Gefitinib Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
24m
Conditions: Lymphedema of Leg; Cancer of Cervix; Cancer, Ovarian; Cancer, Endometrial; Cancer of the Prostate; Malignant Melanoma Interventions: Other: First exercise session + compression; Other: First exercise session - compression Sponsors: Herlev and Gentofte Hospital; University of Copenhagen...
24m
Conditions: Breast Cancer; Postoperative Pain; Anesthesia; Nerve Block Interventions: Procedure: PEC I/II blocks by anesthesiologist - pre-operative; Procedure: PEC I/II blocks by surgeon - intra-operative Sponsor: Melinda Seering Not yet recruiting (Source: ClinicalTrials.gov)
24m
Condition: Non-small Cell Lung Cancer Interventions: Drug: Anlotinib Plus Docetaxel; Drug: Docetaxel Sponsor: First Affiliated Hospital of Guangxi Medical University Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please...
24m
Conditions: Inflammation; Smoking Cessation; Diet Modification; Physical Activity; Lung Cancer Interventions: Drug: Cytisine; Drug: Acetylsalicylic acid; Other: Diet Modification and Physical Activity Increase; Diagnostic Test: early lung cancer detection; Diagnostic Test: spirometry with CO test;...
24m
Conditions: Colorectal Carcinoma; Liver Metastases Interventions: Device: MWA; Radiation: SBRT Sponsor: Rigshospitalet, Denmark Recruiting (Source: ClinicalTrials.gov)
24m
Conditions: Hematologic Malignancy; Hematopoietic/Lymphoid Cancer; Blood Cancer Intervention: Behavioral: Positive Psychology Intervention Sponsors: Dana-Farber Cancer Institute; Harvard Medical School Not yet recruiting (Source: ClinicalTrials.gov)
24m
Condition: Gastric Cancer Intervention: Dietary Supplement: NutrenOpimum Sponsor: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
24m
Conditions: Advanced Solid Tumors; Triple Negative Breast Cancer Intervention: Drug: TT-00420 Sponsor: TransThera Biosciences Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social...
24m
Condition: Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Interventions: Drug: Dasatinib; Other: Laboratory Biomarker Analysis; Drug: Nilotinib; Drug: Ruxolitinib Phosphate Sponsors: Southwest Oncology Group; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
24m
Condition: Head and Neck Cancer Intervention: Drug: Apatinib Sponsors: China International Medical Foundation; Chinese Society of Clinical Oncology Not yet recruiting (Source: ClinicalTrials.gov)
24m
Condition: Prostate Adenocarcinoma Interventions: Combination Product: Dietary Intervention; Other: Questionnaire Administration Sponsors: Ohio State University Comprehensive Cancer Center; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
24m
Condition: Hematopoietic System--Cancer Intervention: Drug: Cyclophosphamide Sponsor: Capital Research Institute of Pediatrics Enrolling by invitation (Source: ClinicalTrials.gov)
24m
Conditions: Leukemia; Brain Tumor; Solid Tumor; Lymphoma Interventions: Drug: ALRN-6924; Drug: Cytarabine Sponsor: Dana-Farber Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com...
24m
Condition: Chemotherapy-induced Peripheral Neuropathy Interventions: Drug: Calmangafodipir (2 µmol/kg); Drug: Calmangafodipir (5 µmol/kg); Drug: Placebo Sponsor: PledPharma AB Not yet recruiting (Source: ClinicalTrials.gov)
24m
Condition: Mesothelioma, Malignant Interventions: Drug: Rucaparib; Drug: Abemaciclib; Drug: pembrolizumab & bemcentinib; Drug: Atezolizumab & Bevacizumab Sponsors: University of Leicester; British Lung Foundation; Clovis Oncology, Inc.; Eli Lilly and Company; Merck Sharp & Dohme Corp.;...
24m
Condition: Colorectal Cancer Intervention: Other: No intervention Sponsors: Sahlgrenska University Hospital, Sweden; Högskolan Väst Active, not recruiting (Source: ClinicalTrials.gov)
24m
Conditions: Recurrent Hepatocellular Carcinoma; Refractory Liver Carcinoma; Stage IV Hepatocellular Carcinoma AJCC v8; Stage IVA Hepatocellular Carcinoma AJCC v8; Stage IVB Hepatocellular Carcinoma AJCC v8 Interventions: Drug: Cyclophosphamide; Biological: IRX-2; Biological: Nivolumab...
24m
Condition: Lung Neoplasm Intervention: Procedure: Lung Tumor Resection Sponsor: The University of Texas Health Science Center at San Antonio Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your...
24m
Condition: Cord Compression Interventions: Radiation: Radiation therapy; Drug: nab-Paclitaxel Sponsors: Washington University School of Medicine; Celgene Not yet recruiting (Source: ClinicalTrials.gov)
24m
Condition: HER2-positive Breast Cancer Intervention: Diagnostic Test: ABY-PET Sponsors: Henrik Lindman; Roche Pharma AG; Swedish Cancer Society; Affibody; Swedish Breast Cancer Group Recruiting (Source: ClinicalTrials.gov)
24m
Condition: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Abemaciclib; Drug: Nivolumab; Procedure: Tumor biopsy; Procedure: Peripheral blood; Other: EORTC QLQ-30 Sponsors: Washington University School of Medicine; Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
24m
Conditions: Breast Cancer; Fatigue; Chronic Pain Intervention: Other: Self-administered acupressure Sponsors: University of Michigan; Substance Abuse and Mental Health Services Administration (SAMHSA); Michigan Opioid Prescribing Engagement Network (Michigan-OPEN) Not yet recruiting (Source:...
24m
Conditions: Hepatocellular Carcinoma; Renal Cell Carcinoma Interventions: Biological: CBT-501; Drug: CBT-101; Biological: Nivolumab Sponsors: CBT Pharmaceuticals (Australia) Pty Ltd; CBT Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking...
24m
Conditions: Cutaneous Melanoma, Stage III; Cutaneous Melanoma, Stage IV Intervention: Biological: IFx-Hu2.0 Sponsors: Morphogenesis, Inc.; H. Lee Moffitt Cancer Center and Research Institute Recruiting (Source: ClinicalTrials.gov)
24m
Conditions: Non Small Cell Lung Cancer; Mesothelioma Intervention: Drug: Pemetrexed Sponsors: Radboud University; ZonMw: The Netherlands Organisation for Health Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
24m
Conditions: Non Small Cell Lung Cancer; Mesothelioma Intervention: Drug: Pemetrexed Sponsors: Radboud University; ZonMw: The Netherlands Organisation for Health Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
24m
Condition: Prostate Cancer Metastatic Interventions: Procedure: radical prostatectomy; Radiation: Whole pelvis radiotherapy Sponsor: University Hospital, Ghent Recruiting (Source: ClinicalTrials.gov)
24m
Conditions: Oral Neoplasm; Pharynx Cancer; Larynx Cancer Interventions: Device: Tritube; Device: Standard enditracheal tube Sponsor: Michael Seltz Kristensen Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before....
24m
Condition: Oesophageal Cancer Intervention: Drug: Durvalumab Sponsors: Simon C Pacey, MD; AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
34m
WellStar says the project will allow it to better serve residents in the medical center's service area of Troup, Meriwether, Harris, Heard and Randolph counties. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)MedWorm Message: Have you tried our new medical search engine? More powerful...
34m
LUNG CANCER symptoms usually develop as the disease progresses and aren 't evident in the early stages. There are, however, signs you should look out for, including this symptom in your fingers. (Source: Daily Express - Health)
1h
AbstractGBM is the highest incidence in primary intracranial malignancy, and it remains poor prognosis even though the patient is gave standard treatment. Despite decades of intense research, the complex biology of GBM remains elusive. In view of eight hallmarks of cancer which were proposed in 2011,...
1h
ConclusionsThis case emphasizes the importance of the differential diagnosis when dealing with patients on immune checkpoint inhibitors because other non-immune-related events may present. Our patient was finally diagnosed with immune-related hyperthyroidism and a concurrent pituitary macroadenoma. This...
